Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Mike Brown

UBS · covers Financial Services

Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q3 (8 quarters; questions recorded in 6).

Questions
34on tracked calls
Challenge rate
6%2 of 34 questions
Companies
9questioned at least once
Reporting periods
6with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 34 of 34 questions from 9 companies

BLKBlackRock7 questions · 6 reporting periods · 1 of 7 challenging
BLK company page →

Calendar 2026 Q3

Maybe just if you could spend a little bit of time unpacking some of the biggest drivers there

Show response

Martin credited performance fee mix in part but said the margin ex performance fees and related comp still expanded 230 basis points on structural growth categories.

what does the margin expansion opportunity look like in 2027, assuming a typical market backdrop?

Show response

Martin pointed to GIP and HPS running at FRE margins north of 50% but gave no numeric 2027 margin target or fourth-quarter margin view.

Calendar 2026 Q2

You reached 45.9% this quarter, so you're tracking to the 45%+ full year guide.

Show response

Martin outlined two structural levers (FRE margin toward 50%+, higher fee rates on flows), noted BlackRock ran ~47% in 2021, and did not see 45-46% as a ceiling.

Calendar 2026 Q1

The Middle East conflict presents some geopolitical and macro challenges that could shift capital priorities

ChallengingMacroeconomicGeographic ExpansionTranscript · FY2026 Q1 →
Show response

Larry reported no sovereign fund withdrawals, continued co-investment participation, and an upcoming retirement win in the Middle East. Noted higher energy costs drive infrastructure and public-private partnership opportunities.

Calendar 2025 Q4

how your differentiated offering like a full spectrum cash to private credit differentiates here

Competitive DynamicsDemandTranscript · FY2025 Q4 →
Show response

Martin detailed $700B insurance general account base with 450+ relationships. Targeting 10% migration from public to private high-grade ($70B opportunity). Combined turnkey capabilities across public fixed income, private credit, Aladdin, accounting and middle office services.

Calendar 2025 Q1

Are you worried about the risk of some assets potentially moving away from the U.S. in general?

MacroeconomicCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Larry emphasized BlackRock's hyper-local approach across 30+ countries since founding 37 years ago. Noted Europe shifting from containment to growth could drive reallocation but macro mega trends unchanged despite trade tensions.

Calendar 2024 Q4

could you just give us some thoughts on maybe the puts and takes that we should consider for the margin in 2025

MarginCost PressureTranscript · FY2024 Q4 →
Show response

Martin outlined disciplined budgeting with mid-to-high single-digit core G&A increase ex-HPS. Noted AUM up $3 trillion since end of 2022 while headcount up only 7%. Expects positive markets to drive further margin expansion.

ARESAres Management Corporation6 questions · 5 reporting periods · 1 of 6 challenging
ARES company page →

Calendar 2026 Q2

any updated views on how we should think about the longer-term fee rate margin profile of the business

MarginCapex InvestmentTranscript · FY2026 Q2 →
Show response

Blair Jacobson said digital-infra fund economics are in line with other Ares offerings, and the vertically integrated model charges back team costs, aiding both returns and Ares economics.

Calendar 2026 Q1

Can you give color on the forward look, how you stress test the portfolio, what you see in underlying fundamentals that give you confidence

ChallengingCreditCloud & AITranscript · FY2026 Q1 →
Show response

Arougheti emphasized the ~40% LTV with 60% equity cushion, approximately 3-year weighted average maturity allowing orderly resolution, continued ~10% EBITDA growth in software portfolio, and opportunistic exits from lower-conviction names.

Calendar 2025 Q4

the idea of getting bigger in private equity came up as part of that interview

M&ACompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Mike outlined PE M&A framework: cultural fit, strategic accretion, financial accretion. Benefits include serving LP demand, deepening equity value creation skills across platform, generating leveraged finance deal flow, and building scale for 401(k)/wealth PE exposure. Cautioned PE doesn't grow linearly at 20%+ like credit/real assets, and growth differential must be reflected in acquisition price.

Calendar 2025 Q1

can you just maybe expand on the potential in '25 versus '24?

Capital AllocationDemandTranscript · FY2025 Q1 →
Show response

Mike described shift from LP-led to balanced GP/LP-led secondaries, expansion across real estate, infrastructure, and credit. University endowments reducing exposure due to research funding cuts and endowment tax concerns.

Calendar 2024 Q4

How should we think about that interplay between the broadly syndicated loan market and the private credit market?

Competitive DynamicsCreditTranscript · FY2024 Q4 →
Show response

Mike argued bank competition narrative is overblown, citing symbiotic relationships. When banks are risk-on, Ares' CLO machine activates. Core middle market differentiation provides pricing resilience. Post-election saw record SRT/CRT and bank portfolio activity.

how's the health of the market there. Does the Trump administration impact some of the growth potential for the region?

MacroeconomicTrade TariffsTranscript · FY2024 Q4 →
Show response

Management noted 2024 European performance exceeded expectations. Portfolio skews toward locally focused companies with limited trade exposure. Investment activity picking up with lower rates.

APOApollo Global Management5 questions · 5 reporting periods · 0 of 5 challenging
APO company page →

Calendar 2026 Q2

Can you still deliver continued margin expansion as you continue to invest in the business?

MarginCapex InvestmentTranscript · FY2026 Q2 →
Show response

Kelly reaffirmed the 20% FRE growth algorithm, mid/high-teens revenue growth against low-teens expense growth, supporting continued margin expansion.

Calendar 2026 Q1

the puts and takes to asset yields and also kind of the higher cost of funds as we move through 26

Show response

Kelly confirmed spread trajectory is tracking expectations with prepayment headwinds expected to dissipate. Defensive positioning includes approximately $40 billion in cash and treasuries.

Calendar 2025 Q4

Can you just unpack a little bit of the implications to SRE here? Just looking at the loans, they have a nice high yield of about 7.7%.

Show response

Rowan explained ARI helps de-risk the 10% SRE growth target but doesn't add to it. Kelly confirmed it fits within the existing guidance framework. Zelter emphasized the principal mindset philosophy behind the transaction.

Calendar 2025 Q1

there's been a lot of negative headlines related to foreign LPs and endowments and kind of reducing their allocations to private markets or, you know, foreign LPs allocating less to The U.S.

MacroeconomicDemandTranscript · FY2025 Q1 →
Show response

Rowan acknowledged some foreign LP pressure but noted U.S. is still 60% of global funding needs. Zelter added that large allocators like Australian super funds have no alternative and Apollo is gaining share.

Calendar 2024 Q4

the no new toys there seems like it's officially done and M&A is kind of back in terms of capital allocation. So I guess in terms of the key strategic opportunities, where else will you focus?

M&ACapital AllocationTranscript · FY2024 Q4 →
Show response

Rowan confirmed M&A is back but scoped to small, origination-focused acquisitions. Cited Argo as prototype. Said size is not material to capital allocation plans.

KKRKKR5 questions · 5 reporting periods · 0 of 5 challenging
KKR company page →

Calendar 2026 Q2

we observed that the management fees declined sequentially. If you're paying AUM growth is also relatively muted

Revenue GrowthCreditTranscript · FY2026 Q2 →
Show response

Direct: attributed the sequential decline to a prior-quarter one-time benefit and pointed to committed-but-not-yet-fee-earning credit capital up 33% year-over-year.

Calendar 2026 Q1

can you just talk about the current fee rate profile there? And then any fundraising expectations over the, call it, next 12 to 24 months

M&ASubscriber GrowthTranscript · FY2026 Q1 →
Show response

Rob declined to share Arctos-specific financials but said profile is generally consistent with KKR's business. Craig noted excitement about global distribution support and potential new wealth solutions including evergreen vehicles.

Calendar 2025 Q4

looking ahead here, what's the potential for this line? Should we expect some balance sheet exits that could move it higher?

Capital AllocationRevenue GrowthTranscript · FY2025 Q4 →
Show response

Rob confirmed upward trajectory for realized investment income over next couple years, potentially meaningful. Noted strategic capital allocation: marginal free cash flow reinvested into strategic M&A, insurance, strategic holdings, and buybacks to increase recurring EPS. Over long term, realized investment income should decrease as percentage of more recurring earnings.

Calendar 2025 Q1

what's the right timeframe to consider for a final close? And then, beyond North America buyout, where else you're expecting

DemandCapital AllocationTranscript · FY2025 Q1 →
Show response

Craig confirmed Infra 5 at $11.3B, Asia infra launch coming shortly, Americas to have multiple closes, then Asia PE launch. Scott noted LTM flagships were just over 20% of total, down from historical levels.

Calendar 2024 Q4

why flat quarter-over-quarter, was there something to call out that drove that?

Competitive DynamicsCapital AllocationTranscript · FY2024 Q4 →
Show response

Craig attributed flat PE returns to small/mid-cap benchmark dynamics (Russell flat vs S&P +2.5%). Scott broadened deployment themes to public-to-privates, carve-outs (best-performing historically), and Japan/Europe opportunities.

BXBlackstone Inc.4 questions · 4 reporting periods · 0 of 4 challenging
BX company page →

Calendar 2026 Q2

curious if you think that some of these, withdrawals will continue to ease as you move into the onshore redemption window.

Show response

Gray attributed easing BCRED redemptions to lower market noise plus extensive adviser outreach, framing it as a repeat of the earlier BREIT experience.

Calendar 2025 Q4

in light of the DOL's proposed rules facilitating the ALTs in 401(k) plans last week, I just wanted to check-in and see if you had kind of updated view on how the market could start to open up

Regulation PolicyProduct LaunchTranscript · FY2025 Q4 →
Show response

Gray expects 2026 to be foundational for 401(k) access with rulemaking, capital raising starting in 2027. Vanguard/Wellington product launch expected in H1 2026. Also filed a hedge fund area product recently.

Calendar 2025 Q1

how do you expect the well flows to hold up broadly? And which asset classes do you think could remain in favor here just given the uncertainty?

Subscriber GrowthDemandTranscript · FY2025 Q1 →
Show response

Gray said two weeks into Q2 there was no pullback in wealth sales, and expected credit to benefit at the margin from a move toward caution.

Calendar 2024 Q4

I'm just hoping to compare and contrast that fund versus BCRED. So the new fund will invest across a variety of credit strategies

Product LaunchCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Gray provided limited detail citing legal constraints, noting the product will span broader credit strategies beyond direct lending in a more accessible structure.

SCHWCharles Schwab Corporation3 questions · 3 reporting periods · 0 of 3 challenging
SCHW company page →

Calendar 2026 Q2

I just wanted to ask maybe one more there on the PAL growth. It continues to be really impressive.

Show response

Attributed PAL growth to easy digital access and clients with concentrated, low-basis positions who prefer to borrow than sell.

Calendar 2025 Q4

How should we think about that longer-term potential? What's the ceiling there?

Show response

Mike described margin expansion as outcome of balanced revenue diversification and expense discipline rather than a specific target. On AI, already seeing efficiency in moderating client-facing rep growth while expanding accounts/assets. Key metrics: EOCA and cost per account.

Calendar 2025 Q1

I just wanted to check in and see if you have an update on how you're approaching the space

Innovation & R&DRegulation PolicyTranscript · FY2025 Q1 →
Show response

Rick reiterated strong crypto engagement including 400% increase in crypto site traffic with 70% prospects, and goal to launch direct spot crypto within 12 months.

Show 3 more companies
IVZInvesco2 questions · 1 reporting period · 0 of 2 challenging
IVZ company page →

Calendar 2025 Q1

can you just expand on that $650 million? How will that be used specifically?

Show response

Andrew clarified seed capital is for product launches only. Barings brings specialty finance and upper-end direct lending; structures not yet filed.

if we consider markets stay flattish from here, is that kind of a baseline?

Cost PressureMarginTranscript · FY2025 Q1 →
Show response

Allison noted comp-to-revenue running 43-44%, Alpha implementation continues at $10-15M/quarter regardless of revenue, and discretionary spending being tightened.

RJFRaymond James Financial1 question · 1 reporting period · 0 of 1 challenging
RJF company page →

Calendar 2026 Q2

are you seeing any indications of kind of adviser interest or adoption thus far?

Show response

Paul stressed stabilizing Clark first before cross-selling, with revenue synergies a future opportunity; answered directly.

TROWT. Rowe Price1 question · 1 reporting period · 0 of 1 challenging
TROW company page →

Calendar 2025 Q1

the cash has now increased to about $2.8 billion. And you just wanted to maybe touch on capital allocation

Capital AllocationM&ATranscript · FY2025 Q1 →
Show response

Jen clarified about half of $3.3B available for strategic opportunities. Rob confirmed stepped-up buyback pace and unchanged M&A framework.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
BLK BlackRock714%1 of 7 questions
ARES Ares Management Corporation617%1 of 6 questions
APO Apollo Global Management50%none of 5 questions
KKR KKR50%none of 5 questions
BX Blackstone Inc.40%none of 4 questions
SCHW Charles Schwab Corporation30%none of 3 questions
IVZ Invesco2—Rate withheld: fewer than 3 questions
RJF Raymond James Financial1—Rate withheld: fewer than 3 questions
TROW T. Rowe Price1—Rate withheld: fewer than 3 questions
  • BLK
    BlackRock · 7 questions
    14%1 of 7 questions
  • ARES
    Ares Management Corporation · 6 questions
    17%1 of 6 questions
  • APO
    Apollo Global Management · 5 questions
    0%none of 5 questions
  • KKR
    KKR · 5 questions
    0%none of 5 questions
  • BX
    Blackstone Inc. · 4 questions
    0%none of 4 questions
  • SCHW
    Charles Schwab Corporation · 3 questions
    0%none of 3 questions
  • IVZ
    Invesco · 2 questions
    —rate withheld: under 3 questions
  • RJF
    Raymond James Financial · 1 question
    —rate withheld: under 3 questions
  • TROW
    T. Rowe Price · 1 question
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q460%none of 6 questions5
2025 Q190%none of 9 questions8
2025 Q2No questions recorded——
2025 Q3No questions recorded——
2025 Q460%none of 6 questions6
2026 Q1450%2 of 4 questions4
2026 Q270%none of 7 questions7
2026 Q320%none of 2 questions1
  1. 2024 Q46 questions · challenge rate 0% (none of 6 questions) · 5 companies
  2. 2025 Q19 questions · challenge rate 0% (none of 9 questions) · 8 companies
  3. 2025 Q2No questions recorded
  4. 2025 Q3No questions recorded
  5. 2025 Q46 questions · challenge rate 0% (none of 6 questions) · 6 companies
  6. 2026 Q14 questions · challenge rate 50% (2 of 4 questions) · 4 companies
  7. 2026 Q27 questions · challenge rate 0% (none of 7 questions) · 7 companies
  8. 2026 Q32 questions · challenge rate 0% (none of 2 questions) · 1 company

Topics

Topics tagged on this analyst’s questions.

  • Margin10
  • M&A7
  • Credit6
  • Demand6
  • Competitive Dynamics6
  • Capital Allocation6
  • Product Launch4
  • Macroeconomic4
  • Capex Investment2
  • Revenue Growth2
Show all 18 topics
  • Cloud & AI2
  • Subscriber Growth2
  • Regulation Policy2
  • Cost Pressure2
  • Pricing1
  • Geographic Expansion1
  • Innovation & R&D1
  • Trade Tariffs1